Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Pasqualini

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Clinical Immunology (Orlando, Fla.)|August 17, 2004
Selective induction of pentraxin 3, a soluble innate immune pattern recognition receptor, in infectious episodes in patients with haematological malignancyBasel K al-Ramadi, Michael Ellis, Fabio Pasqualini, et al.
Bladder (San Francisco, Calif.)|August 1, 2025
<i>SPEF1</i> and <i>SPEF2</i> as potential biomarkers in bladder cancer: Insights from a comprehensive bioinformatic analysisMohamed A A A Hegazi, Fabio Pasqualini, Maurizio Chiriva-Internati, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 2, 2010
PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditisManuela Nebuloni, Fabio Pasqualini, Pietro Zerbi, et al.
Journal of Leukocyte Biology|October 16, 2002
High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administrationBeat Müller, Giuseppe Peri, Andrea Doni, et al.
American Journal of Obstetrics and Gynecology|May 2, 2006
Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restrictionIrene Cetin, Veronica Cozzi, Fabio Pasqualini, et al.
Discovery Medicine|March 26, 2024
Investigating the Spatial Distribution of Proliferating Cells in Primary Ovarian CancersMohamed A A A Hegazi, Fabio Pasqualini, Gianluigi Taverna, et al.
European Journal of Immunology|September 30, 2003
Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cellsAndrea Doni, Giuseppe Peri, Marcello Chieppa, et al.
The Journal of Infectious Diseases|October 23, 2012
Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapyMoira Paroni, Federica Moalli, Manuela Nebuloni, et al.
Journal of the Society for Gynecologic Investigation|March 7, 2006
Follicular fluid levels of the long pentraxin PTX3Alessio Paffoni, Guido Ragni, Andrea Doni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
The CCL3 family of chemokines and innate immunity cooperate in vivo in the eradication of an established lymphoma xenograft by rituximabElena Cittera, Marzia Leidi, Chiara Buracchi, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Clinical Immunology (Orlando, Fla.)|August 17, 2004
Selective induction of pentraxin 3, a soluble innate immune pattern recognition receptor, in infectious episodes in patients with haematological malignancyBasel K al-Ramadi, Michael Ellis, Fabio Pasqualini, et al.
Bladder (San Francisco, Calif.)|August 1, 2025
<i>SPEF1</i> and <i>SPEF2</i> as potential biomarkers in bladder cancer: Insights from a comprehensive bioinformatic analysisMohamed A A A Hegazi, Fabio Pasqualini, Maurizio Chiriva-Internati, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 2, 2010
PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditisManuela Nebuloni, Fabio Pasqualini, Pietro Zerbi, et al.
Journal of Leukocyte Biology|October 16, 2002
High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administrationBeat Müller, Giuseppe Peri, Andrea Doni, et al.
American Journal of Obstetrics and Gynecology|May 2, 2006
Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restrictionIrene Cetin, Veronica Cozzi, Fabio Pasqualini, et al.
Discovery Medicine|March 26, 2024
Investigating the Spatial Distribution of Proliferating Cells in Primary Ovarian CancersMohamed A A A Hegazi, Fabio Pasqualini, Gianluigi Taverna, et al.
European Journal of Immunology|September 30, 2003
Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cellsAndrea Doni, Giuseppe Peri, Marcello Chieppa, et al.
The Journal of Infectious Diseases|October 23, 2012
Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapyMoira Paroni, Federica Moalli, Manuela Nebuloni, et al.
Journal of the Society for Gynecologic Investigation|March 7, 2006
Follicular fluid levels of the long pentraxin PTX3Alessio Paffoni, Guido Ragni, Andrea Doni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
The CCL3 family of chemokines and innate immunity cooperate in vivo in the eradication of an established lymphoma xenograft by rituximabElena Cittera, Marzia Leidi, Chiara Buracchi, et al.
Pageof 6